Nesyrgy (Amlodipine Besilate, Nebivolol Hydrochloride)

Amlodipine besilate and nebivolol hydrochloride, the active ingredient in Nesyrgy, is a calcium channel blocker / beta‑blocker combination presented as a tablet for oral use. It treats hypertension in adult patients.

GNH USA supplies Nesyrgy as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nesyrgy is a dual‑action antihypertensive that acts on the vascular and cardiac pathways to lower elevated blood pressure.

Essential hypertension: lowers systolic and diastolic pressure in patients with primary hypertension. Stage 1 hypertension: helps achieve target blood pressure in early‑stage disease. Stage 2 hypertension: provides additional control when monotherapy is insufficient.

Common Side Effects: - Headache - Peripheral edema - Dizziness - Flushing - Fatigue - Palpitations

Serious or Rare Side Effects: - Severe hypotension - Bradycardia or heart block - Angioedema - Liver enzyme elevation - Allergic reactions such as rash or urticaria - Syncope

Before initiating therapy, clinicians should assess cardiovascular status and monitor for adverse reactions.

Monitor blood pressure: adjust dose based on response. Assess cardiac function: avoid in patients with severe heart failure. Use caution in hepatic impairment: dose may need adjustment. Avoid abrupt discontinuation: taper to prevent rebound hypertension. Review concomitant medications: consider additive effects. Store at below 25°C: keep in the original pack, protect from moisture.

Nesyrgy may interact with several drug classes; careful review is required.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole) may increase amlodipine levels. - Non‑dihydropyridine calcium channel blockers (verapamil, diltiazem) can raise nebivolol concentrations. - Concurrent use with other antihypertensives may cause excessive hypotension. - Grapefruit juice can elevate plasma levels of both components. - Alpha‑blockers may lead to marked blood pressure drops.

Moderate Interactions (Monitor Closely): - Diuretics may increase risk of electrolyte imbalance. - NSAIDs can blunt antihypertensive effect. - Antidiabetic agents may require dose adjustment due to enhanced glucose lowering. - Lithium levels may rise, necessitating monitoring. - CYP2D6 substrates (e.g., metoprolol) may need dose modification.